Perinatal transmission of hepatitis B virus infection and vaccination in China
- PMID: 8786051
- PMCID: PMC1398041
- DOI: 10.1136/gut.38.suppl_2.s37
Perinatal transmission of hepatitis B virus infection and vaccination in China
Abstract
Hepatitis B remains one of the most important infectious diseases in China. In 1980, an overall hepatitis B virus (HBV) infection rate of 42.6% was reported and a hepatitis B surface antigen (HBsAg) carrier rate of 10.3%. HBsAg positivity among children under 1 year of age ranged from 5.1% in Beijing to 7% in Guangdong. A peak in carrier rate was observed in 7 to 14 year olds, reaching 24% in Guangdong. During the past decade, there has been no significant change in overall HBV carrier rates. However, in areas where hepatitis B vaccination for all neonates has been introduced, a decline in HBsAg positivity in lower age groups has been observed. Perinatal transmission is believed to account for 35-50% of carriers although horizontal transmission is also important, particularly within families. Infants born to HBeAg positive carrier mothers are at even greater risk of infection. HBV infection during childhood leads to an increased risk of serious longterm sequelae, including hepatocellular carcinoma (HCC). It is hoped that universal childhood immunisation will allow control of HBV infections in China within a few generations.
Similar articles
-
Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.Gut. 1996;38 Suppl 2(Suppl 2):S39-42. doi: 10.1136/gut.38.suppl_2.s39. Gut. 1996. PMID: 8786052 Free PMC article. Review.
-
Hepatitis B vaccination in children: the Taiwan experience.Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29. Pathol Biol (Paris). 2010. PMID: 20116181
-
Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.Vaccine. 2017 Jul 24;35(33):4229-4235. doi: 10.1016/j.vaccine.2017.06.019. Epub 2017 Jun 23. Vaccine. 2017. PMID: 28651839
-
[Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].Zhonghua Gan Zang Bing Za Zhi. 2013 Feb;21(2):105-10. doi: 10.3760/cma.j.issn.1007-3418.2013.02.008. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 23663881 Clinical Trial. Chinese.
-
Hepatitis B virus infection.Semin Fetal Neonatal Med. 2007 Jun;12(3):160-7. doi: 10.1016/j.siny.2007.01.013. Epub 2007 Feb 28. Semin Fetal Neonatal Med. 2007. PMID: 17336170 Review.
Cited by
-
Deficient knowledge on hepatitis B infection in pregnant women and prevalence of hepatitis B surface antigen carriage in an endemic area: a review.Hepat Res Treat. 2012;2012:317451. doi: 10.1155/2012/317451. Epub 2012 Sep 28. Hepat Res Treat. 2012. PMID: 23056935 Free PMC article.
-
Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.Biomed Res Int. 2020 Apr 27;2020:1374276. doi: 10.1155/2020/1374276. eCollection 2020. Biomed Res Int. 2020. PMID: 32420317 Free PMC article.
-
Prevention of vertical transmission of hepatitis B: an observational study.Ann Intern Med. 2014 Jun 17;160(12):828-35. doi: 10.7326/M13-2529. Ann Intern Med. 2014. PMID: 24862434 Free PMC article.
-
Hepatitis B (prevention).BMJ Clin Evid. 2009 Sep 23;2009:0916. BMJ Clin Evid. 2009. PMID: 21726479 Free PMC article.
-
Evaluation and management of hepatitis B in pregnancy: a survey of current practices.Gastroenterol Hepatol (N Y). 2010 Sep;6(9):570-8. Gastroenterol Hepatol (N Y). 2010. PMID: 21088746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous